Your browser doesn't support javascript.
loading
MhcVizPipe: A Quality Control Software for Rapid Assessment of Small- to Large-Scale Immunopeptidome Datasets.
Kovalchik, Kevin A; Ma, Qing; Wessling, Laura; Saab, Frederic; Duquette, Jérôme D; Kubiniok, Peter; Hamelin, David J; Faridi, Pouya; Li, Chen; Purcell, Anthony W; Jang, Anne; Paramithiotis, Eustache; Tognetti, Marco; Reiter, Lukas; Bruderer, Roland; Lanoix, Joël; Bonneil, Éric; Courcelles, Mathieu; Thibault, Pierre; Caron, Etienne; Sirois, Isabelle.
Affiliation
  • Kovalchik KA; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Ma Q; School of Electrical Engineering and Computer Science, Faculty of Engineering, University of Ottawa, Ontario, Canada.
  • Wessling L; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Saab F; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Duquette JD; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Kubiniok P; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Hamelin DJ; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Faridi P; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Li C; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Purcell AW; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Jang A; CellCarta, Montreal, Quebec, Canada.
  • Paramithiotis E; CellCarta, Montreal, Quebec, Canada.
  • Tognetti M; Biognosys, Schlieren, Switzerland.
  • Reiter L; Biognosys, Schlieren, Switzerland.
  • Bruderer R; Biognosys, Schlieren, Switzerland.
  • Lanoix J; Institute of Research in Immunology and Cancer, Montreal, Quebec, Canada.
  • Bonneil É; Institute of Research in Immunology and Cancer, Montreal, Quebec, Canada.
  • Courcelles M; Institute of Research in Immunology and Cancer, Montreal, Quebec, Canada.
  • Thibault P; Institute of Research in Immunology and Cancer, Montreal, Quebec, Canada; Department of Chemistry, Université de Montréal, Montreal, Quebec, Canada.
  • Caron E; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada; Department of Pathology and Cellular Biology, Faculty of Medicine, Université de Montréal, Quebec, Canada. Electronic address: etienne.caron@umontreal.ca.
  • Sirois I; CHU Sainte-Justine Research Center, Montreal, Quebec, Canada. Electronic address: isabelle.sirois.phd@gmail.com.
Mol Cell Proteomics ; 21(1): 100178, 2022 01.
Article in En | MEDLINE | ID: mdl-34798331
ABSTRACT
MS-based immunopeptidomics is maturing into an automatized and high-throughput technology, producing small- to large-scale datasets of clinically relevant major histocompatibility complex (MHC) class I-associated and class II-associated peptides. Consequently, the development of quality control (QC) and quality assurance systems capable of detecting sample and/or measurement issues is important for instrument operators and scientists in charge of downstream data interpretation. Here, we created MhcVizPipe (MVP), a semiautomated QC software tool that enables rapid and simultaneous assessment of multiple MHC class I and II immunopeptidomic datasets generated by MS, including datasets generated from large sample cohorts. In essence, MVP provides a rapid and consolidated view of sample quality, composition, and MHC specificity to greatly accelerate the "pass-fail" QC decision-making process toward data interpretation. MVP parallelizes the use of well-established immunopeptidomic algorithms (NetMHCpan, NetMHCIIpan, and GibbsCluster) and rapidly generates organized and easy-to-understand reports in HTML format. The reports are fully portable and can be viewed on any computer with a modern web browser. MVP is intuitive to use and will find utility in any specialized immunopeptidomic laboratory and proteomics core facility that provides immunopeptidomic services to the community.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Software / Histocompatibility Antigens Class I Type of study: Prognostic_studies Language: En Journal: Mol Cell Proteomics Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2022 Type: Article Affiliation country: Canada

Full text: 1 Database: MEDLINE Main subject: Software / Histocompatibility Antigens Class I Type of study: Prognostic_studies Language: En Journal: Mol Cell Proteomics Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2022 Type: Article Affiliation country: Canada